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Copyright © 2009 JCBN Summary D-Psicose is a rare sugar present in small quantities in natural products. In a
previous study, we showed that D-psicose suppresses plasma glucose increases and reduces
body fat accumulation in rats. Based on acute toxicity testing in rats, D-psicose is classified as
an ordinary substance (LD50 = 16 g/kg). Elucidating the effects of long term feeding of D-
psicose in rats will be essential prior to its utilization as a physiologically functional food. In
this study, male Wistar rats (3 weeks old) were fed diets containing 3% D-psicose or sucrose
for 12–18 months. The rats actually ingested 1.28 g/kg body weight per day D-psicose or
1.22 g/kg body weight per day of sucrose. Body weight gain and intra-abdominal adipose tissue
weight in rats fed the D-psicose diet for 18 months were significantly lower than those in rats
fed the sucrose diet. Relative weights of liver and kidney were significantly higher in the D-
psicose group than in the sucrose group. However, no gross pathological findings were evident
at dietary doses of 3% D-psicose or correlated with hypertrophy of liver and kidney. No
clinical chemical test value was suggestive of overt D-psicose treatment-related toxicity.
Therefore, the present study found no adverse effects at 3% D-psicose in the diet.
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Introduction
D-psicose (D-ribo-2-hexulose), a C-3 epimer of D-
fructose, is a “rare sugar” present in small quantities in
commercial mixtures of D-glucose and D-fructose obtained
from hydrolysis of sucrose or isomerization of D-glucose
[1]. D-psicose is also present in processed cane and beet
molasses [2], and is found in wheat [3], Itea plants [4], and
in the antibiotic psicofranine [5]. Because of the very small
amounts of D-psicose in natural products, few studies have
examined D-psicose metabolism in animals.
Recently, we developed a new method to produce D-
psicose enzymatically on a large scale [6,  7], making it
possible to conduct studies of bioactivity and applications
in food and medicine. Examining the effects of D-psicose on
glucose and lipid metabolisms, we found that D-psicose is a
sweet monosaccharaide that provides no energy to growing
rats and leads to less intra-abdominal fat accumulation than
D-glucose and D-fructose in rats [8, 9]. In addition, we have
suggested that supplemental D-psicose can lower plasma
glucose levels [10].
Based on acute toxicity testing in rats, D-psicose is
classified as an ordinary substance; the LD50 value was
16 g/kg orally in rats [11]. D-psicose, which is contained
in foods such as fruit juice and fruit cereal, is derived from
D-fructose in the cooking process [2,  12]. Thus, most
humans ingest a limited amount of D-psicose on a daily
basis. However, the effects of long-term feeding of D-
psicose must be elucidated prior to utilization as a physio-
logically functional food.
In this study, to assess D-psicose safety, oral 12-month
and 18-month toxicity studies were conducted with rats
at dietary doses of 3% D-psicose. The objective was to
determine whether or not D-psicose can be used as a food.K. Yagi and T. Matsuo
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Materials and Methods
All procedures involving animals were approved by the
Animal Care Committee of the Kagawa University.
Animals and experimental diets
Thirty-six male Wistar rats (3 weeks old) were obtained
from Japan SLC (Shizuoka, Japan). They were fed CE-2, a
commercial rodent diet (CLEA, Tokyo, Japan) and water ad
libitum until they were 4 weeks old. They were caged
individually at 22 ± 2°C, with light from 08:00 to 20:00 h.
The rats were randomly divided into two groups of 18 (the
sucrose and D-psicose groups). We adopted sucrose as a
control of D-psicose because sucrose is a most popular
sweet carbohydrate and is used in many studies as control
saccharide [13–15]. The experimental diets were 3% sucrose
or D-psicose added to the CE-2. The amount of test carbo-
hydrates (3%) was decided in reference to previous studies
concerning sucralose with the LD50 level (16 g/kg weight)
same as D-psicose [11, 16, 17]. Each group of rats was given
free access to the food and water for 12 or 18 months. D-
psicose was donated by the Rare Sugar Center of Kagawa
University. Sucrose was purchased from Wako Pure Chemical
Industries (Osaka, Japan).
Experimental Design
After 12 months of feeding, 8 rats in each group were
fasted 4.5 h from 06:00 h, then anesthetized with intra-
peritoneal administration of sodium pentobarbital. Blood
was collected from the abdominal aorta for clinical hemato-
logical analysis and to obtain serum for chemical analysis.
The rats were allowed to exsanguinate. The remainders of
the rats (10 rats in each group) were killed at the end of 18
months in a similar manner. The brain, heart, lungs, liver,
pancreas, kidneys, adrenals, spleen, testicles, intra-abdominal
adipose tissues (epididymal, perirenal and mesenteric) and
muscle tissues (soleus, gastrocnemius and plantarius) were
quickly removed and weighed. Parts of the liver and kidney
were preserved in 10% neutral buffered formalin for histo-
pathological examinations. The stomach, small intestine,
large intestine and cecum were also quickly removed and
weighed. In addition, the small and large intestine length,
surface area and cecal content weight were measured.
Analysis
The following hematological and clinical chemistry para-
meters were evaluated platelet count (PLT), hemoglobin
(Hb), erythrocyte count (RBC), leukocyte count (WBC),
hematocrit (HCT), mean corpuscular volume (MCV), mean
corpuscular hemoglobin (MCH), mean corpuscular hemo-
globin concentration (MCHC), glucose (GLU), insulin (ISL),
triglycerides (TG), free fatty acids (FFA), total cholesterol
(CHO), aspartate aminotransferase (AST), alanine amino-
transferase (ALT), total bilirubin (TBIL), direct bilirubin
(DBIL), indirect bilirubin (IBIL), creatinine (CREA), urea
nitrogen (BUN), uric acid (UA), albumin (ALBU), total
protein (TP), ratio of albumin and globulin (A/G), lipid
peroxide (LPO), Ca, and Fe. Hematological analysis was
requested from SRL Co., Ltd. (Tokyo, Japan). Concentra-
tions of serum glucose, triglycerides and peroxide lipid were
determined by methods reported previously [18–20]. Serum
insulin concentration was determined using a kit (Rat Insulin
EIA System, Amersham Bioscience, Tokyo, Japan). Serum
iron concentration was measured by flame atomic absorp-
tion spectrophotometry (AAS Z-5000, Hitachi, Tokyo,
Japan) after diluted samples with 0.1 M HNO3. Other
analyses of clinical chemistry were determined using a kit
(Wako Pure Chemical Industries, Osaka, Japan). Evaluation
of histopathological examinations was requested from Fuji
Biomedix (Yamanashi, Japan). Then, histopathological
levels in each rat were subjectively quantified as follows
score: (−;0, ±;1, +;2, ++;3, +++;4).
Statistical analysis
All values were expressed as mean ± SD. Statistical
analysis of differences between the sucrose and D-psicose
groups was performed with Student’s t test. Statistical
significance was set at p value of <0.05. All analyses were
performed with a commercially available statistical package
(Stat View J-5.0, SAS Institute Inc., Cary, NC).
Results
Body and tissue weights, energy intake and digestive tract
size
Results of body and tissue weights, energy intake and
digestive tract size in rats fed for 12 or 18 months are
presented in Tables 1 and 2, respectively. Final body weight,
weight gain and energy intake did not differ between the
sucrose and the D-psicose group at 12 months (Table 1). At
18 months, final body weight and weight gain in the D-
psicose group were significantly lower than in the sucrose
group, through energy intake did not differ between the 2
groups (Table 1). The rats actually ingested 1.28 g/kg body
weight per day D-psicose or 1.22 g/kg body weight per day
of sucrose. Livers and kidneys at 12 months were signifi-
cantly heavier in the D-psicose group than in the sucrose
group, but no differences were observed in any other tissue
weights (Table 1). Livers and kidneys at 18 months were
also significantly heavier in the D-psicose group than in the
sucrose group, and higher weights were also observed in
brains, lungs and pancreas in the D-psicose group compared
to the sucrose group (Table 1). In contrast, relative intra-
abdominal adipose tissues at 18 months were significantly
lighter in the D-psicose group than in the sucrose group
(Table 1). Digestive tract size in rats fed for 12 months didLong-Term Toxicity of D-psicose
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not differ between the sucrose and the D-psicose group
(Table 2). Cecal content weight in rats fed for 18 months
was significantly higher in the D-psicose group than in the
sucrose group, but no differences were observed in size
(Table 2).
Hematological values
Hematology results in rats fed for 12 or 18 months are
presented in Table 3. MCH at 12 months was significantly
lower in the D-psicose group than in the sucrose group,
but no differences were observed in any of the related
hematology values (Table 3). Hb and MCV at 18 months
were significantly greater in the D-psicose group than in
the sucrose group, but no differences were observed in any
of the related hematology values (Table 3).
Clinical chemistry
Serum chemical analysis results from rats fed for 12
months are presented in Table 4. All chemical values did not
differ between the sucrose and D-psicose groups (Table 4).
Histopathological examination
Histopathological observations of the liver and kidneys
are presented in Tables 5 and 6, respectively. Age-related
Table 1. Body weight, Energy intake and Tissue weights
Values are means ± SD for 8–10 rats. *,**Significant difference from the Sucrose group (*p<0.05, **p<0.01, Student’s t tests).
†Relative tissue weights per 100 g final body weight.
Groups
12 months 18 months
Sucrose D-Psicose Sucrose D-Psicose
Initial weight (g) 87 ± 89 1 ± 28 2 ± 10 79 ± 12
Final weight (g) 446 ± 13 435 ± 17 405 ± 15 346 ± 28**
Weight gain (g) 360 ± 7 344 ± 17 322 ± 13 285 ± 22**
Energy intake (kcal/day) 62.7 ± 2.8 64.6 ± 1.7 59.5 ± 3.0 60.2 ± 4.2
Tissue weights†
Brain (g/100 g) 0.45 ± 0.02 0.46 ± 0.02 0.50 ± 0.02 0.54 ± 0.04**
Heart (g/100 g) 0.21 ± 0.01 0.21 ± 0.01 0.21 ± 0.01 0.22 ± 0.02
Lungs (g/100 g) 0.26 ± 0.01 0.26 ± 0.02 0.28 ± 0.02 0.31 ± 0.01*
Liver (g/100 g) 3.26 ± 0.18 3.69 ± 0.19** 3.12 ± 0.27 3.84 ± 0.24**
Pancreas (g/100 g) 0.12 ± 0.02 0.13 ± 0.03 0.13 ± 0.02 0.17 ± 0.02**
Kidneys (g/100 g) 0.63 ± 0.03 0.74 ± 0.03** 0.64 ± 0.03 0.81 ± 0.05**
Adrenals (g/100 g) 0.01 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 0.01 ± 0.00
Spleen (g/100 g) 0.20 ± 0.03 0.21 ± 0.04 0.23 ± 0.01 0.25 ± 0.04
Testicles (g/100 g) 0.71 ± 0.03 0.71 ± 0.07 1.02 ± 0.30 0.92 ± 0.10
Intra-adipose tissues (g/100 g) 8.27 ± 0.62 8.17 ± 0.97 7.63 ± 0.30 5.79 ± 1.04**
Muscle tissues (g/100 g) 0.05 ± 0.00 0.05 ± 0.00 0.05 ± 0.00 0.06 ± 0.01
Table 2. Digestive tracts size
Values are means ± SD for 8–10 rats. *Significant difference from the Sucrose group (*p<0.01, Student’s t tests).
Groups
12 months 18 months
Sucrose D-Psicose Sucrose D-Psicose
Stomach contents (g) 2.33 ± 0.46 2.52 ± 0.90 2.91 ± 0.62 3.59 ± 1.19
weight (g) 1.26 ± 0.08 1.21 ± 0.15 1.66 ± 0.24 1.72 ± 0.18
Small intestine weight (g) 2.62 ± 0.51 2.86 ± 0.20 3.42 ± 0.84 4.02 ± 0.42
length (m) 1.18 ± 0.03 1.17 ± 0.05 1.09 ± 0.17 1.10 ± 0.05
Large intestine weight (g) 1.05 ± 0.15 1.20 ± 0.20 1.33 ± 0.28 1.26 ± 0.28
length (×10−2 · m) 18.7 ± 1.7 19.8 ± 1.1 16.8 ± 1.0 14.5 ± 3.7
Cecum contents (g) 6.62 ± 0.96 6.84 ± 0.97 7.09 ± 0.65 9.07 ± 1.59*
weight (g) 0.62 ± 0.07 0.62 ± 0.04 0.95 ± 0.16 0.99 ± 0.22
surface area (×103 · mm2)3 . 0 2 ± 0.28 3.01 ± 0.27 2.80 ± 0.55 3.00 ± 0.27K. Yagi and T. Matsuo
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naturally occurring lesions were observed in the liver and
kidneys at 12 months, but no abnormality due to ingestion of
D-psicose was observed (Table 5). Histopathologic observa-
tion of the liver at 18 months, revealed fatty degeneration
and hepatocellular fibrosis were observed in the D-psicose
group and not in the sucrose group (Table 6). These findings
tended to be slight and local. The hepatocellular fibrosis
observed in one sample of the D-psicose group (out of 8
samples) was extremely mildly. Histopathological observa-
tion at 12 months showed no difference in total pathological
lesions between the sucrose and the D-psicose groups
(Liver, 4.13 vs 3.13; Kidney, 12.3 vs 14.1 (Mean scores))
(Table 5). In the liver at 18 months, the mean value for
pathological lesions was significantly higher in the D-
Psicose group than in the sucrose group (2.75 vs 3.75 (Mean
scores)), but the difference was slight (p<0.0498) (Table 6).
In the kidneys at 18 months, the total value for pathological
lesions did not differ between the sucrose and the D-psicose
groups (14.0 vs 14.1 (Mean scores)) (Table 6).
Discussion
The present study demonstrated that the effects of 3% D-
psicose in the diet after long-term administration to rats were
increased relative weights of liver and kidneys. However,
hematological, chemical and histopathological examinations
Table 3. Hematological values
Values are means ± SD for 8–10 rats. *Significant difference from the Sucrose group (*p<0.01, Student’s t tests).
Groups
12 months 18 months
Sucrose D-Psicose Sucrose D-Psicose
PLT (×104/mm3) 76.2 ± 9.0 83.7 ± 5.9 76.3 ± 14.5 75.1 ± 11.5
Hb (g/100 ml) 14.5 ± 0.6 14.2 ± 0.5 15.4 ± 0.9 14.1 ± 0.6*
RBC (×104/mm3) 817 ± 37 838 ± 21 876 ± 51 838 ± 36
WBC (/μl) 2914 ± 518 2900 ± 1003 3729 ± 1533 3560 ± 1180
HCT (%) 45.0 ± 2.0 45.2 ± 1.3 47.9 ± 6.2 45.5 ± 1.6
MCV (μ3)5 5 ± 15 4 ± 15 6 ± 25 4 ± 1*
MCH (pg) 18 ± 11 7 ± 0* 17 ± 11 7 ± 0
MCHC (%) 32 ± 13 1 ± 13 1 ± 13 1 ± 1
Table 4. Clinical chemistry values at 12 months
Values are means ± SD for 8 rats.
Groups Sucose D-Psicose
GLU (mg/100 ml) 176 ± 27 170 ± 20
ISL (ng/ml) 6.76 ± 1.35 6.34 ± 1.12
TG (mg/100 ml) 139 ± 7 154 ± 23
FFA (mEq/l) 0.56 ± 0.08 0.55 ± 0.09
CHO (mg/100 ml) 126 ± 36 121 ± 28
ALBU (g/l) 3.85 ± 0.3 3.92 ± 0.18
TP (g/l) 6.92 ± 0.36 7.16 ± 0.81
A/G 1.27 ± 0.22 1.28 ± 0.33
AST (IU/l) 122 ± 35 125 ± 26
ALT (IU/l) 69.8 ± 19.6 73.2 ± 13.4
TBIL (mg/100 ml) 0.47 ± 0.18 0.68 ± 0.35
DBIL (mg/100 ml) 0.27 ± 0.10 0.43 ± 0.28
IBIL (mg/100 ml) 0.19 ± 0.17 0.25 ± 0.21
CREA (mg/100 ml) 0.70 ± 0.07 0.76 ± 0.09
BUN (mg/100 ml) 17.7 ± 2.1 18.3 ± 1.1
UA (mg/100 ml) 1.39 ± 0.29 1.30 ± 0.34
LPO (nmol MDA/ml) 2.88 ± 1.00 2.44 ± 0.63
Ca (mg/100 ml) 10.4 ± 1.2 10.7 ± 1.1
Fe (mg/l) 1.66 ± 0.25 1.50 ± 0.17Long-Term Toxicity of D-psicose
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Table 5. Histopathological observations of liver and kidneys at 12 months




12345678 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6
Organs Findings




Total score 33 25
Kidneys Basophilic change in the tubule + ++ ±±+ + ++ ++ + + + ++ + + + + ± ++
Hyaline cast in the tubule + ++ ± + ++ +++ + ++ ++ +++ +++ ++ ++ ++ + +++
Brown pigment deposition in the tubule ++ + + + ++ + + + + + ± ++ +++ ++
Atrophy of the glomerulus −±−−−+ −− −−−−−+ −±
Hyalinization in the glomerulus ± + −−++ +±± ++ + + ±±+ ± +
Thickening of Bowman’s capsule basement membrane ± ++ ±±++ +± ++ + + + ±± ++ ± ++
Lymphocyte infiltration in the interstitium + ++ ±±± ++ ± ++ + ++ +++ ± ++ +± ++
Scores† 11 17 6 7 13 20 10 14 13 16 18 10 12 17 9 18
Total score 98 113
Table 6. Histopathological observations of liver and kidneys at 18 months
†Quantify the findings level in each rats; −: 0, ±: 1, +: 2, ++: 3, +++: 4.




12345678 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6
Organs Findings
L i v e r B i l e  d u c t  p r o l i f e r a t i o n ++++++++ ++± + ± +++
Necrosis −−−−−−−− −−−+ −−−−
Microgranuloma ±±±−±±±− −±±±±±±±
Fatty degeneration −−−−−−−− ±−+ −−−+ ±
Fibrosis with brown pigmentation −−−−−−−− −−−−−−±−
Scores† 33323332 33452364
Total score 22 30*
Kidneys Basophilic change in the tubule ++ ++ ++ ++ ++ ++ ++ + ++ ++ ++ ++ ++ ++ ++ ++
Hyaline cast in the tubule ++ ++ ++ +++ +++ +++ + ++ +++ +++ +++ +++ +++ +++ +++ +++
Brown pigment deposition in the tubule + + ++++++ ++++++++
Atrophy of the glomerulus −−−±±±+ −± − ± + ±±−+
Hyalinization in the glomerulus ± + ± ++++± +++++++ + +
Thickening of Bowman’s capsule basement membrane ±±±++++± + ± ++++++
Lymphocyte infiltration in the interstitium + ± ++++++ ++++++++
Scores† 12 12 12 16 16 16 17 11 16 14 16 17 16 16 15 18
Total score 112 113K. Yagi and T. Matsuo
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revealed no values suggestive of overt D-psicose treatment-
related toxicity.
Previous testing found that the LD50 value of D-psicose
orally in rats was 16 g/kg [11]. In the present study, rats
actually ingested 1.28 g/kg body weight per day of D-
psicose or 1.22 g/kg body weight per day of sucrose. Body
weight gain and intra-abdominal adipose tissue weight in
rats fed the D-psicose diet for 18 months were significantly
lower than those in rats fed the sucrose diet. We previously
reported that D-psicose supplements suppress hepatic lipo-
genic enzyme activity and reduce intra-abdominal fat
accumulation more effectively than D-glucose or D-fructose
supplements in rats [9, 21]. In addition, we found that D-
psicose is a sweet monosaccharide that provides no energy
to growing rats [8]. The present findings support our pre-
vious results. However, rats fed the D-psicose diet for 12
months did not differ from the sucrose group in most para-
meters studied, which indicates that D-psicose did not
inhibit rat growth. Thus, low dietary levels (3% of diet or
less) of D-psicose over an extended period primarily
affected fat accumulation.
In a previous short-term toxicity test in rats, we showed
that the feeding of diets extremely high in D-psicose
appeared to be harmful to the intestinal tract [11, 22]. More-
over, we previously reported that cecal weight, cecal surface
area and cecal content weight increased with increases of
D-psicose in diets (above 10%) [11, 22]. D-psicose is partly
absorbed in the digestive tract and is excreted into urine
and feces. However, it is also fermented in the cecum by
intestinal microflora, producing short-chain fatty acids as a
soluble dietary fiber [22,  23]. In this study, no adverse
effects on the intestinal tract were seen at 3% D-psicose in
the diet at 12 months. However, cecal content weight in the
D-psicose group at 18 months was significantly higher than
in the sucrose group. These findings suggest that short-chain
fatty acids due to intestinal fermentation accumulated in the
cecum during long-term administration of D-psicose. Thus,
3% D-psicose in the diet does not appear to be harmful to the
intestinal tract. Sucralose, a low-calorie artificial sweetener
and with the acute-toxicity of the level same as D-psicose,
has also been reported to increase cecal weight in the short-
term toxicity test, but this has been recognized as a non-toxic
effect [16].
In this study’s hematological analysis, dietary D-psicose
significantly decreased the MCH value at 12 months
compared to sucrose, and significantly increased the Hb and
MCV values at 18 months. These findings suggest no overt
D-psicose toxicity, because the values remain within the
normal range.
Dietary D-psicose increased the weights of livers and
kidneys. This finding agrees with our previous studies
[10, 11,  24]. Bilirubin, a bile pigment, is produced from
hemoglobin and is used as an index of hepatic function.
Blood bilirubin concentration increases when hepatopathy
and homolytic disease occurs. Blood levels of AST and
ALT are also used as indexes of hepatic damages. These
values in this study did not differ between D-psicose and
sucrose. In addition, histopathologic observations of the
liver and kidneys revealed no abnormalities due to ingestion
of D-psicose. Liver enlargement occurs in animals and
humans under a variety of conditions with different conse-
quences for health [25]. For example, it can be the result of
a physiological adaptation to an enhanced workload or
metabolic demand, a metabolic abnormality, a toxic effect,
an inflammatory process, or a proliferative disease. Bar et al.
[26] found that D-tagatose, a rare sugar, increases liver
glycogen deposition and relative liver weights in non-fasting
rats at dietary levels of 5–20%. D-tagatose is an incom-
pletely absorbed ketohexose (stereo isomer of D-fructose)
that has potential as an energy-reduced alternative sweet-
ener. Bar et al. concluded that the liver enlargement seen in
response to the consumption of D-tagatose was a physio-
logical response to treatment-induced increased glycogen
deposition. We previously found some D-psicose treatment-
induced increase in glycogen deposition (unpublished
dates). However, these results lacked clarity. It is unknown
whether these mechanisms of the liver enlargement induced
by D-psicose and D-tagatose are the same.
Final body weights of both sucrose and D-psicose groups
were lower at 18 months than at 12 months. The cause of
weight reduction is regarded as a decrease of energy intake
by the aging. However, why the weight reduction ratio of
D-psicose group is greater than that of sucrose group is not
clear.
In conclusion, the present study found the effects of long-
term 3% D-psicose administration to rats to be increased
liver and kidney weights with no gross pathological findings
correlated with this hypertrophy. Hematological and chemical
values were not suggestive of overt D-psicose toxicity.
Overall, no adverse effects were seen at this low-dose of
D-psicose in the diet.
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